vac bno 1095
Botanicalexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
3
Phase 4
0
Earliest trial started Mar 1, 2011 (NCT01309113)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vac bno 1095
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06211049 | Phase 3 | Dec 12, 2023 | Bionorica, FGK Clinical Research GmbH |
| NCT01870687 | Phase 3 | Jun 1, 2013 | Bionorica |
| NCT01309113 | Phase 3 | Mar 1, 2011 | Bionorica, PHAMOS Central and Eastern Europe |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bionorica | For profit | 3 | 3 | 1 | 2011 |
| FGK Clinical Research GmbH | For profit | 1 | 0 | 1 | 2023 |
| PHAMOS Central and Eastern Europe | For profit | 1 | 0 | 1 | 2011 |
3 organizations
Page 1 / 1